MaxCyte, Inc. (MXCT) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc. (NASDAQ: MXCT) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $7.27 million versus the consensus estimate of $6.63 million.
For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- UBS Upgrades Mitsubishi Heavy Industries Ltd (7011:JP) (MHVYF) to Buy
- Axis Capital Limited Downgrades National Aluminium (NACL:IN) to Sell (4)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
